CNTX
Price
$2.00
Change
+$0.20 (+11.11%)
Updated
May 17, 6:59 PM EST
82 days until earnings call
HRMY
Price
$29.03
Change
-$0.25 (-0.85%)
Updated
May 17, 6:59 PM EST
74 days until earnings call
Ad is loading...

CNTX vs HRMY

Header iconCNTX vs HRMY Comparison
Open Charts CNTX vs HRMYBanner chart's image
Context Therapeutics
Price$2.00
Change+$0.20 (+11.11%)
Volume$393.8K
CapitalizationN/A
Harmony Biosciences Holdings
Price$29.03
Change-$0.25 (-0.85%)
Volume$201.27K
CapitalizationN/A
View a ticker or compare two or three
CNTX vs HRMY Comparison Chart

Loading...

CNTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
HRMYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CNTX vs. HRMY commentary
May 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTX is a StrongBuy and HRMY is a StrongBuy.

COMPARISON
Comparison
May 18, 2024
Stock price -- (CNTX: $2.00 vs. HRMY: $29.31)
Brand notoriety: CNTX and HRMY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTX: 85% vs. HRMY: 76%
Market capitalization -- CNTX: $150M vs. HRMY: $1.65B
CNTX [@Biotechnology] is valued at $150M. HRMY’s [@Biotechnology] market capitalization is $1.65B. The market cap for tickers in the [@Biotechnology] industry ranges from $593.52B to $0. The average market capitalization across the [@Biotechnology] industry is $2.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTX’s FA Score shows that 0 FA rating(s) are green whileHRMY’s FA Score has 0 green FA rating(s).

  • CNTX’s FA Score: 0 green, 5 red.
  • HRMY’s FA Score: 0 green, 5 red.
According to our system of comparison, HRMY is a better buy in the long-term than CNTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTX’s TA Score shows that 4 TA indicator(s) are bullish while HRMY’s TA Score has 2 bullish TA indicator(s).

  • CNTX’s TA Score: 4 bullish, 4 bearish.
  • HRMY’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, CNTX is a better buy in the short-term than HRMY.

Price Growth

CNTX (@Biotechnology) experienced а +6.95% price change this week, while HRMY (@Biotechnology) price change was -6.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

Reported Earning Dates

CNTX is expected to report earnings on Aug 08, 2024.

HRMY is expected to report earnings on Jul 30, 2024.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CNTX with price predictions.
OPEN
A.I.dvisor published
a Summary for HRMY with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
HRMY($1.65B) has a higher market cap than CNTX($150M). CNTX YTD gains are higher at: 76.991 vs. HRMY (-9.257).
CNTXHRMYCNTX / HRMY
Capitalization150M1.65B9%
EBITDAN/AN/A-
Gain YTD76.991-9.257-832%
P/E RatioN/A12.51-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
CNTXHRMY
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 10 days ago
77%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 1 day ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
68%
View a ticker or compare two or three
Ad is loading...
CNTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
HRMYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSLIX6.050.03
+0.50%
Transamerica Small Cap Value I
PMDAX18.540.05
+0.27%
Principal Small-MidCap Dividend Inc A
DVLCX24.72N/A
N/A
BNY Mellon Opportunistic Midcap Value C
PGSVX11.98N/A
N/A
Pioneer Global Sustainable Value A
VSMSX407.32-0.57
-0.14%
Vanguard S&P Small-Cap 600 Index I

HRMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRMY has been loosely correlated with RVNC. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if HRMY jumps, then RVNC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRMY
1D Price
Change %
HRMY100%
-1.31%
RVNC - HRMY
39%
Loosely correlated
-4.53%
CYTK - HRMY
37%
Loosely correlated
-0.96%
GYRE - HRMY
37%
Loosely correlated
-2.18%
CALA - HRMY
37%
Loosely correlated
N/A
PRTA - HRMY
32%
Poorly correlated
+4.47%
More